K36 Therapeutics Funding & Investors
Cambridge, MA
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
k36tx.comTotal Amount Raised: $100,000,000
K36 Therapeutics Funding Rounds
Series B
$70,000,000
Series B Investors
Nextech InvestAtlas VentureEight Roads VenturesF-Prime CapitalBristol-Myers SquibbSeries A
$30,000,000
Series A Investors
Atlas VentureEight Roads VenturesF-Prime Capital
Funding info provided by Diffbot.